Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Non-cash Items (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Non-cash Items for 2 consecutive years, with $400000.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 815.5% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Dec 2025, up 815.5% year-over-year, with the annual reading at $64485.0 for FY2025, N/A changed from the prior year.
  • Non-cash Items for Q4 2025 was $400000.0 at Neuphoria Therapeutics, down from $453013.0 in the prior quarter.
  • The five-year high for Non-cash Items was $453013.0 in Q3 2025, with the low at $43692.0 in Q4 2024.